fda warning letters glp-1 september 2025 news 8, 2025: launches an import alert listing safe manufacturers – Partnership for Safe Medicines FDA takes aim at telehealth

McGarry, A

Prescription Priorities and Insurance Coverage 52% feel that those needing the drugs for weight-related health issues should be prioritized

Looking toward the future The wheels of progress on multi-agonists, oral small molecules, and tissue-targeted approaches are moving forward at breakneck speed

GLUCAGON-LIKE PEPTIDE-1 As discussed earlier, glucagon is known to promote hyperglycemia and it seems counterintuitive to use it as treatment in those with diabetes

Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinsons disease

doi: 10.1016/S0002-9378(96)70221-1 [DOI] [PubMed] [Google Scholar] 66